Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN11992428Phase 4Completed
Phase 4, randomised, open-label trial of sodium fluoride in carious lesion (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Primary clinical endpoint. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN11992428.